News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Pre-Clinical (World)
Positive Data From Cynata MSCs In Second Preclinical Asthma Study 8/23/2017
Luxcel Biosciences Announce Further EU H2020 Success With €1.5million Award And Rapid Expansion Plans 7/26/2017
Midatech: Completion Of Pre-Clinical Liver Cancer Programme 7/26/2017
TRANSGENE (ENX:TNG) Announces Cancer Research Publication Confirming The Potential Of Its Next Generation Armed Engineered Oncolytic Virus 7/24/2017
Angle: Preclinical Study Presented At Tumor Boston Summit 7/20/2017
Preclinical Study Using Parsortix, Inc. Presented At Tumor Models Boston Summit 7/20/2017
ProMis Neurosciences Presents At AAIC 2017 Data From Alzheimer's Disease Program 7/19/2017
Axovant (AXON) Release: New Preclinical Data For Intepirdine Suggests Potential Neuroprotective Properties 7/19/2017
Onxeo Announces Positive Preclinical Proof Of Concept Results Confirming AsiDNA Activity via Systemic Administration 7/5/2017
ObsEva (OBSV) Announces Presentations Related To Its Assisted Reproductive Technology (ART) And Pre-Term Labor (PTL) Development Programs At ESHRE 2017 Annual Meeting 6/29/2017
European Hematology Association: Delayed Exposure To Common Infections Causes Acute Leukemia Of Childhood 6/23/2017
Recce (RCE) Constructs Automated Manufacturing Facility To Support Clinical Trials 6/22/2017
Inventiva Announces Peer Review Publication Of IVA337 Data In Pre-Clinical NASH Models 6/22/2017
OSE Immunotherapeutics Presents Positive Preclinical Results And Human Ex Vivo Data For OSE-127 (Effi-7) To Support Next Clinical Applications In Inflammatory Bowel Diseases At The Federation Of Clinical Immunology Societies (FOCIS) Conference 6/15/2017
Drug Candidates Developed Using Zymeworks’ Azymetric Platform Nominated For Late-Stage, Preclinical Development By Eli Lilly (LLY) 6/12/2017
Alligator Bioscience Advances 4-1BB Immuno-Oncology Antibody ATOR-1017 To Pre-Clinical Development 6/12/2017
Mithra Pharmaceuticals Receives Orphan Drug Designation From EMA For E4 In Neonatal Encephalopathy 6/9/2017
ASLAN Announces New Positive Data Identifying ASLAN003 As A Novel Therapeutic Agent In Acute Myeloid Leukaemia 6/7/2017
Affimed (AFMD) Presents Data On First-In-Class BCMA-Targeting Immune Cell Engager AFM26 At ASCO Annual Meeting 2017 6/6/2017
Theravance Biopharma (TBPH) Release: New Data Highlighting In Vitro Potency Advantages For VIBATIV (Telavancin) Against Difficult-To-Treat MRSA And MSSA Pathogens Reported At ASM Microbe 2017 6/5/2017
Poxel (POXEL.PA) To Present New Preclinical Imeglimin Data On Protective Benefits From Diabetic Cardiomyopathy At American Diabetes Association Meeting 5/30/2017
Phoenix Molecular Designs Announces New Preclinical Data For Targeted Triple Negative Breast Cancer (TNBC) Therapy 5/25/2017
NeuroVive (NVP) To Continue Neurostat Clinical Development After Positive Outcome In Preclinical And Clinical TBI Studies 5/23/2017
Galapagos (GLPG.BR) Release: Seven Abstracts On Filgotinib Accepted By EULAR 2017 5/16/2017
Isarna Therapeutics Presents Positive Clinical Data For ISTH0036 In Advanced Glaucoma And Preclinical Data Supportive Of AMD/DME Potential At ARVO 2017 Annual Conference 5/15/2017
Pharmaleads Reports Positive Ocular Pain Results With PL265, A Novel Dual Enkephalinase Inhibitor (DENKI), At The Association for Research in Vision & Ophthalmology 2017 Annual Meeting 5/12/2017
PharmaMar: Sylentis Announces New Preclinical And Clinical Data For Its SYL1001 Molecule During Association for Research in Vision & Ophthalmology 2017 5/9/2017
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Preclinical Analgesic Effects 5/9/2017
Stainwei Granted U.S. Patent For Anti-VEGF Monoclonal Antibody And Its Anti-PD-1 Mab Demonstrating Prolonged Anti-Tumor Activity In Pre-Clinical Studies 5/3/2017
Pluristem Therapeutics (PSTI) Announces Promising Results From Non-Human Primate Pilot Study Of PLX-R18 In Acute Radiation Syndrome 5/3/2017
Galapagos (GLPG.BR) Presents Pre-Clinical Data With Selective ADAMTS-5 Inhibitor GLPG1972 For Osteoarthritis At OARSI 5/1/2017
ASKA Pharmaceutical And TesoRx Announce TSX-011 (Oral Testosterone) Proceeding To Human Studies Following Successful PK Study Results 4/27/2017
uniQure (QURE) Presents New Preclinical Data On AMT-130 In Huntington’s Disease At CHDI’s 12th Annual Huntington’s Disease Therapeutics Conference 4/26/2017
PROMETHERA Biosciences S.A./N.V. Presents Preclinical Data On Novel H2Stem Cell Therapy At EASL International Liver Congress 4/21/2017
Inventiva Announces Presentation Of Preclinical Results On IVA337 In NASH At The International Liver Congress 2017 (EASL) 4/20/2017
Protalix (PLX) Announces New Preclinical Results Demonstrating A Positive Effect Of Pegunigalsidase Alfa (PRX-102) On Small-Fiber Neuropathy In Fabry Disease Models Compared To Commercially Available Enzyme Replacement Therapies 4/18/2017
Recce (RCE) Operational Update 4/10/2017
Hutchison China MediTech (Chi-Med) Presented Pre-Clinical Data For Fruquintinib And Sulfatinib At The AACR Annual Meeting 2017 4/7/2017
Eisai Company (ESALY.PK) Presents Data Of Mechanisms Of Action Relating To Tumor Immune Response Regarding Combination Of Anticancer Agent Lenvatinib With Anti-PD-1 Antibody At AACR 108th Annual Meeting 4/5/2017
amcure Presents Preclinical Data On Lead Cancer Compound AMC303 At AACR Annual Meeting 4/4/2017
TRANSGENE (ENX:TNG) Presents Very Promising New Immunology Data Of Its Next Generation Armed Oncolytic Virus At The AACR Annual Meeting In Washington, DC 3/31/2017
TRANSGENE (ENX:TNG) Presents Very Promising New Immunology Data Of Its Next Generation Armed Oncolytic Virus At The AACR Annual Meeting In Washington, DC 3/30/2017
VAXIMM To Present Preclinical Data On Three Novel Oral T-Cell Immunotherapies At AACR Annual Meeting 2017 3/30/2017
PHARNEXT To Present New PXT864 Synergy Data At AD/PDTM 2017, The 13th International Conference On Alzheimer's And Parkinson's Diseases And Related Neurological Disorders 3/29/2017
Alkermes (ALKS) To Present Preclinical Data On ALKS 4230 At AACR Annual Meeting 3/27/2017
Old Blood Can Be Made Young Again, University of Ulm Scientists Reveal 3/24/2017
University of Liverpool Release: Results Of Mouse Studies Deeply Affected By The Way The Animals Are Handled 3/22/2017
ERYtech Pharma Presents New Preclinical Anti-Tumor Data On Erymethionase At AACR 2017 3/21/2017
OWC Pharmaceutical Research Corp. Releases Promising Preliminary Results From Efficacy Tests Of Its Topical Cream 3/21/2017
ObsEva (OBSV) To Present Pharmacology Results Demonstrating OBE022 Exerts A Synergistic Effect In Combination With Standard Of Care In Animal Model For Preterm Labor 3/17/2017
ERYtech Pharma To Present Preclinical Results Supporting Immunotherapy Potential Of ERYMMUNE Platform At Two Upcoming Medical Meetings 3/7/2017
Artificial Embryo Shows Early Potential For Medical Therapies, Not Babies, Cambridge University Study Reveals 3/3/2017
Cynata Advances Development Of Cymerus MSCs For The Treatment Of Asthma 3/2/2017
Luxcel Biosciences And HD Biosciences Co., Ltd Enter Collaboration Agreement For Mitochondria Toxicity & Metabolism Assays For Preclinical Drug Safety Evaluation 3/1/2017
Onxeo Appoints Seasoned Executives To Accelerate Preclinical And Clinical Development 3/1/2017
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Prevents Progression Of Liver Fibrosis 2/28/2017
Mologen (MOLGF.PK): First Combination Data Of TLR9 Agonists Enandim With Checkpoint Inhibitor In Preclinical Tumor Models 2/27/2017
MabSpace Biosciences To Present Preclinical Data On Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property At Upcoming Inaugural ASCO-SITC Clinical Immuno-Oncology Symposium 2/23/2017
IGC Launches Phytocannabinoid Development Committee To Secure Preclinical Initiatives For IGC-501, IGC-502 And IGC-504 2/13/2017
NeuroVive (NVP) Release: Pharma Presents Positive Preclinical Data In Hepatocellular Cancer At HCC Summit 1/19/2017
Recce (RCE) Release: Pharma’s Lead Compound Reduces Illness In Mice Infected By Resistant E. Coli Bacteria 1/18/2017
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Statistically Significant Efficacy In A Highly Translational Preclinical Model Of Chronic Osteoarthritis Pain 1/9/2017
XTL Biopharma (XTLB)' Preclinical Studies of hCDR1 Demonstrate Therapeutic Potental In the Treatment of Sjögren's Syndrome 1/5/2017
Benitec (BLT.AX) Releases Pivotal Data In An In Vivo Hepatitis B Model 12/20/2016
New Preclinical Data Show Can-Fite BioPharma (CFBI)'s Namodenoson (CF102) Inhibits Liver Fibrosis -- Supports Potential Efficacy In Treatment Of NASH 12/16/2016
ABIVAX Reports New Preclinical Data Supporting ABX464 As HIV Functional Cure And Novel Treatment For Inflammatory Diseases At HIV DART Meeting 12/9/2016
BerGenBio AS Release: New Breast Cancer Research Highlights BGB324 In Overcoming Immunotherapy Resistance 12/8/2016
VAXIMM Presents Preclinical Data On Three Novel Oral T-Cell Cancer Immunotherapies At EORTC-NCI-AACR Symposium 12/1/2016
AiCuris Announces U.S. NIH Support Of Preclinical Study With AIC649 Against Chronic Hepatitis B 11/23/2016
Novartis AG (NVS) and Google (GOOG)’s Verily Miss Smart Contact Lens Human Trial Goal 11/22/2016
Probiodrug AG Release: Amyloid-beta (Abeta) Aggregate-Clearing By The Murine Anti-Pyroglutamate-3 Abeta IgG2a Monoclonal Antibody PBD-C06 With And Without A Complement Mutation In An Alzheimer’s Mouse Model 11/16/2016
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/15/2016
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating Its Potential Usage As In Situ Vaccine For Cancer At The Society For Immunotherapy Of Cancer Annual Meeting 11/14/2016
Compugen Ltd. (CGEN) Immune Checkpoint Program Demonstrates Potential For Development Of New Cancer Immunotherapy Treatments 11/11/2016
Onxeo Announces Promising Results From Preclinical Studies Of Livatag In Pancreatic Cancer 11/4/2016
Cantargia To Present New Data From Preclinical Studies With CAN04 In Non-Small Cell Lung Cancer 10/20/2016
Cynata's Technology Significant Efficacy In Preclinical Asthma Study 10/17/2016
OSE Immunotherapeutics To Present The Preclinical Data Of Its New Checkpoint Inhibitor Effi-DEM On SIRP-a/CD47 Strategic Pathway At The 2016 Immune Checkpoint Inhibitors Conference 10/4/2016
MiNA Announces Presentation Of Pre-Clinical Data Supporting On-Target Mechanism Of Action Of Clinical Candidate MTL-CEBPA 9/27/2016
BerGenBio AS: New BGB324 Study Points To Novel Mechanism To Enhance Immunotherapy Efficacy 9/26/2016
Probiodrug AG Release: Combination Therapy With Glutaminyl Cyclase (QC) Inhibitor PQ912 And pGlu-Abeta Specific Antibody PBD-C06 Shows Clear Additive Effects In Reducing pGlu-Abeta As Well As Abeta In Alzheimer-Mouse Model 9/13/2016
Interferon Shows Promise As Flu Therapy, Francis Crick Institute in London Study 9/7/2016
Onxeo: Combination Of Asidna And PARP Inhibitors Demonstrates Synergistic Effect, Bypasses Genetic Restriction 9/7/2016
Promising New Findings For Probiodrug AG's Glutaminyl Cyclase - Inhibitor In An Inflammation Animal Model 9/7/2016
Can Pomegranates Protect The Brain From Dementia? University of New South Wales Reveals 9/1/2016
European Society of Cardiology Congress Poster Session Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells for Chronic Ischemic Cardiomyopathy 8/29/2016
European Society of Cardiology Congress Presentation Reveals Results From Pre-Clinical Study Using CardioCell's Stem Cells For Acute Myocardial Infarction (AMI) 8/29/2016
Basilea (BSLN.SW) Ends Further Development of Inhaled Antibiotic BAL30072 8/15/2016
iX Biopharma Is Developing Its Next Drug In Pain Management 8/10/2016
Synaffix Achieves Significantly Improved Therapeutic Index Compared To Both FDA-Approved ADCS And Expands Its Scientific Advisory Board 7/20/2016
Alcobra (ADHD) Granted European Orphan Drug Designation For Metadoxine In Fragile X Syndrome 7/19/2016
Fangyuan Pharma Plans Trials Of New-To-China Antibiotic 7/13/2016
Strekin AG Announces The Presentation Of Key STR001 Data At The Conference On Molecular Biology Of Hearing And Deafness, Cambridge UK 7/1/2016
DBV Tech Announces Publication Of Preclinical Data In JACI Suggesting EPIT Provides Sustained Protection Against Anaphylaxis 6/13/2016
Onxeo Announces Development Of Beleodaq Oral Formulation Opening New Opportunities For Its HDAC Inhibitor 6/2/2016
TopiVert Completes TOP1630 Preclinical Development 5/16/2016
Can-Fite BioPharma (CFBI) To Present Data On Cf602 In The Treatment Of Erectile Dysfunction At American Urological Association's Annual Meeting 5/2/2016
NeuroVive (NVP) Starts Preclinical TBI Program In Collaboration With University of Pennsylvania 4/26/2016
Affimed (AFMD) Presents Data On AFM13-Mediated Innate/Adaptive Immune Crosstalk At The AACR Annual Meeting 2016 4/21/2016
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016
Combinations Of Viralytics Ltd (VLA.AX) CAVATAK And Checkpoint Immunotherapy Demonstrate Anti-Cancer Activity In Preclinical Lung Cancer And Melanoma Studies 4/19/2016
Compugen Ltd. (CGEN) Achieves Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer (BAY) 4/18/2016
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Research At The 2016 AACR Annual Meeting 4/18/2016
BerGenBio AS Presents New Data Demonstrating That BGB324 Enhances Checkpoint Inhibitor Blockade 4/18/2016
Can-Fite BioPharma (CFBI) Announces New Pre-Clinical Data For CF602 Demonstrating Statistically Significant Full Recovery From Erectile Dysfunction After A Single Dose 4/11/2016
NewPhase Successfully Completed Small Mammal Pre-Clinical Trials Of A Cancer Treatment That Transforms Cancer To A Treatable Chronic Ailment 4/11/2016
OWC Pharmaceutical Research Corp. Advances Its Multiple Myeloma Study To Animals 3/29/2016
BioCad Release: Innovative Russian Medicine Mobilizes Human Immune System To Fight Cancer 3/23/2016
Can-Fite BioPharma (CFBI) To Present At BIO CEO & Investor Conference In New York City On February 8, 2016 2/5/2016
Allergan (AGN) Release: Rapastinel (GLYX-13) Shown To Improve Ketamine Or PCP-Induced Cognitive Impairment In Mice 1/19/2016
Glide Technologies Announces Successful Proof-Of-Concept With Novel Exenatide Solid Dose Formulation 1/6/2016
Akari Therapeutics Announces Additional Data From Non-Human Primate Safety Study Demonstrating Equivalent Coversin Efficacy In Both Elisa CH50 And Hemolytic SRBC Assays 1/5/2016
Preclinical Validation Of Oncodesign SA’s First Radiotracer Prior To Human Application 12/17/2015
AstraZeneca PLC (AZN)'s New R&D Approach Involves Diving into the Secretome 12/14/2015
BioLineRx Ltd. To Host Investor Breakfast In New York On December 3, 2015 11/25/2015
MGB Biopharma Limited Successfully Completes Feasibility Study With Topical Formulation Of Its Lead Antibacterial MGB-BP-3 11/17/2015
PHARNEXT's Pleodrug PXT-864 Demonstrates Positive Effects In Parkinson's Disease Preclinical Data Published In Nature's Scientific Reports 11/10/2015
Virttu Biologics Shows Robust Evidence Of Immunological Activity In Mesothelioma Patients Following SEPREHVIR Administration Results To Be Presented At Society For ImmunoTherapy Of Cancer (SITC) 11/5/2015
Hutchison China MediTech (Chi-Med) Release: Sulfatinib Clinical Results And Fruquintinib-Savolitinib Combination Preclinical Results To Be Presented At The 2015 AACR-National Cancer Institute-EORTC Molecular Targets And Cancer Therapeutics Conference 10/30/2015
Clasado And University of Oxford Demonstrate Latest Series Of Effects Of Advanced Prebiotic On Neuro-Inflammation And Anxiety In Pre-Clinical Study 10/27/2015
Probiodrug AG Presented Data On Its pglu-3 Abeta Monoclonal Antibody At Neuroscience 2015, Chicago 10/19/2015
OncoQR’s Breast Cancer Vaccine Successfully Completes Pre-Clinical Proof-of-Concept Study 10/15/2015
Kuros Biosurgery AG To Present Positive kur-115 Pre Clinical Data For Interbody Spinal Fusion Treatment At The 2015 North American Spine Society 10/15/2015
Addex Therapeutics (ADXN.SW)' ADX71441 Demonstrates Robust Efficacy In Multiple Preclinical Models Of Alcohol Use Disorder 10/13/2015
Protalix Biotherapeutics, Inc. (PLX) To Explore Non Alcoholic Steato Hepatitis (NASH) As An Indication For Its PRX 106 Oral Anti TNF 10/5/2015
Addex Therapeutics (ADXN.SW) ADX71149 Demonstrates Synergistic Efficacy With Levetiracetam In Preclinical Models Of Epilepsy 9/23/2015
BerGenBio AS Release: BGB324 Enhances Immune Checkpoint Inhibitor Efficacy In Preclinical Cancer Models 9/21/2015
Summit Therapeutics Presents New Positive Preclinical Data On Novel C. difficile Antibiotic SMT19969 At ICAAC 2015 9/18/2015
Debiopharm And Solid Biosciences, LLC, Announce A Collaboration To Explore The Use Of Alisporivir (Debio 025) In Muscular Dystrophy 9/8/2015
Novogen Limited (NVGN) Announces The Outcome Of A Comprehensive Science Review 8/31/2015
greenovation Biotech GmbH Release: Fabry Enzyme Replacement Therapy (ERT) Based On Mannose-Mediated Cellular Uptake Shows Encouraging Preclinical Results That Allow Start Of Early Clinical Trials 8/27/2015
Amarantus BioSciences, Inc. Announces A New Eltoprazine Publication Confirming The Long-Term Efficacy And Elucidating The Mechanism Of Action In PD-LID 8/5/2015
GenKyoTex S.A. ’s NOX1&4 Inhibitor Strategy In Liver Fibrosis Supported By New Preclinical Results 7/30/2015
New Data Show Pluristem Therapeutics (PSTI)s PLX Cells Regulate The Immune System 7/27/2015
Yissum Ltd. Introduces A Novel Technology For Drug Screening And Testing Of Orphan Diseases Without Utilizing Animal Models 7/27/2015
CEVEC Pharma's CAP(R)Go Derived Recombinant Placental Human Alkaline Phosphatase Shows Superior Results In A Preclinical Study 7/6/2015
Can-Fite BioPharma (CFBI)'s CF602 Sexual Dysfunction Drug Backed By New Preclinical Data Progresses Towards An IND 6/29/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Read-Through Platform In Spinal Muscular Atrophy (SMA) 6/22/2015
BioBlast Pharma (ORPN) To Present Preclinical Proofs Of Concept In Spinal Muscular Atrophy And Friedreich's Ataxia At Two Leading Scientific Meetings In June 6/18/2015
Bionomics Limited (BNO.AX) Files Patent For Use Of BNC105 In Combination With PD-1 And CTLA-4 Immuno-Oncology Antibodies 6/15/2015
Tikcro Technologies To Proceed With CTLA4 And PD1 Antibody Generation Plan 6/15/2015
Protalix Biotherapeutics, Inc. (PLX) Announces AIR Dnase Data Presented At The 38th European Cystic Fibrosis Conference 6/12/2015
Presentations On Two Novel Zealand Pharma  (ZEAL.CO) Preclinical Peptide Therapeutics As Possible Approaches For The Treatment Of Type 2 Diabetes And Obesity At The American Diabetes Association's 74th Scientific Sessions 6/8/2015
MGB Biopharma Limited Succeeds In Developing An IV Formulation Of MGB-BP-3 For The Treatment Of Systemic Susceptible And Resistant Gram-Positive Hospital-Acquired Infections 6/2/2015
Genticel Announces Positive Preclinical Proof Of Concept Results Of GTL002, Its New Multivalent HPV Therapeutic Vaccine Candidate Based On Company's Versatile Vaxiclase Platform 6/1/2015
Onxeo Announces Preclinical & Clinical Data From Three Studies Supporting The Potential For Belinostat In Multiple Orphan Oncology Indications 5/28/2015
Zealand Pharma  (ZEAL.CO) Starts Clinical Development Of A Multiple-Dose Version Of Its Stable Glucagon Analogue, ZP4207 5/20/2015
Novogen Limited (NVGN) Release: Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 5/8/2015
Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating Opregen Preserves Vision 5/4/2015
Medivir AB (MVRBF): Positive Preclinical Antiviral And Safety Profile Of MIV-802 Supports Continued Development 4/23/2015
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015
DelMar Pharmaceuticals Presents Positive Preclinical Data On Val-083 For Treatment Of Non-Small Cell Lung Cancer At AACR Annual Meeting 4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015
BioBlast Pharma (ORPN) Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 3/30/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Admedus HPV Vaccine Heads To The Clinic 11/24/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
nanoMR Inc. Lands $21.5 Million Deal 11/7/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014
Compugen Ltd. (CGEN) Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer AG (BAYZF) 10/14/2014
Kadimastem Received A Quick Response From The FDA: The Development Process For The Stem Cell-Based Drug For ALS Is Expected To Be Significantly Shortened 10/7/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
Cell Reports Publication On The Mechanism Of Action Of NOXXON’s Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) In Preclinical Multiple Myeloma Models 9/26/2014
Sirona Biochem Launches Anti-aging Preclinical Studies 9/23/2014
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 8/25/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014
Scancell Release: Synergy Of SCIB1 With Checkpoint Inhibitors 8/12/2014
Cannabis Science Inc. Initiates Pre-Clinical Studies On Cannabinoid Formulations In Neurological Diseases Including Sleep Disorders With The Highly Reputable Institute For Health And Science On Ageing - INRCA - In Italy 8/4/2014
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
BiOptix And Altermune Technologies Present At Drug Analysis 2014 6/27/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014



//-->